CONMED Corporation (CNMD)

Pretax margin

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 85,506 137,688 145,283 163,030 160,071 123,897 103,804 80,829 29,608 25,039 -85,863 -70,861 -30,675 -28,948 80,820 73,105 56,955 56,866 7,843 1,603
Revenue (ttm) US$ in thousands 1,347,471 1,326,246 1,315,998 1,307,015 1,288,116 1,275,993 1,261,548 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458
Pretax margin 6.35% 10.38% 11.04% 12.47% 12.43% 9.71% 8.23% 6.49% 2.53% 2.20% -7.82% -6.78% -2.87% -2.78% 7.92% 7.23% 5.76% 5.81% 0.89% 0.19%

September 30, 2025 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $85,506K ÷ $1,347,471K
= 6.35%


Peer comparison

Sep 30, 2025

Company name
Symbol
Pretax margin
CONMED Corporation
CNMD
6.35%
Abbott Laboratories
ABT
18.56%
Stryker Corporation
SYK
17.97%